
Windtree Therapeutics WINT
Quartalsbericht 2025-Q3
hinzugefügt 23.05.2026
Windtree Therapeutics ROA 2011-2026 | WINT
ROA Jährlich Windtree Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -6.41 | -62.61 | -103.3 | -90.44 | -28.85 | -23.09 | -17.2 | -551.12 | -407.16 | -124.32 | -92.76 | -50.64 | -124.82 | -157.67 | -131.9 | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -6.41 | -551.12 | -131.49 |
ROA Vierteljährlich Windtree Therapeutics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -233.26 | -99.43 | -32.08 | -16.97 | -29.24 | -36.48 | -6.28 | -40.22 | -48.66 | -69.84 | -65.68 | -54.0 | -63.68 | -96.39 | -69.53 | -57.42 | -65.41 | -64.2 | -28.84 | -22.25 | -28.44 | -26.44 | -23.39 | -23.09 | -24.47 | -21.77 | -18.91 | -17.2 | 64.26 | -95.07 | -294.25 | -551.12 | -693.08 | -616.68 | -524.48 | -407.16 | -361.87 | -324.22 | -240.2 | -124.32 | -123.93 | -99.2 | -96.04 | -92.76 | -83.5 | -73.34 | -60.64 | -50.62 | -60.25 | -91.14 | -105.32 | -124.62 | -134.14 | -125.23 | -162.0 | -157.35 | -35.66 | -60.61 | -28.8 |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 64.26 | -693.08 | -124.01 |
ROA anderer Aktien in der Pharmaeinzelhändler
| Name | ROA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
-241.53 | - | 5743.5 % | $ 69.7 M | ||
|
MorphoSys AG
MOR
|
-20.13 | - | 2.43 % | $ 254 M | ||
|
Happiness Biotech Group Limited
HAPP
|
-22.19 | - | 1.35 % | $ 17.8 M | ||
|
Compugen Ltd.
CGEN
|
22.57 | $ 2.09 | -6.08 % | $ 195 M | ||
|
AgeX Therapeutics
AGE
|
-275.96 | - | -10.17 % | $ 12.2 K | ||
|
Coherus BioSciences
CHRS
|
65.04 | $ 1.47 | -6.67 % | $ 172 M | ||
|
I-Mab
IMAB
|
7.43 | - | - | $ 866 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
-41.16 | - | - | $ 2.18 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
3.33 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
23.87 | - | 2.54 % | $ 160 B | ||
|
Biophytis SA
BPTS
|
-142.36 | - | -13.47 % | $ 169 M | ||
|
AstraZeneca PLC
AZN
|
8.97 | - | - | $ 96.9 B | ||
|
BioNTech SE
BNTX
|
-5.17 | $ 88.04 | -1.73 % | $ 21.3 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-53.39 | - | -1.52 % | $ 24.7 M | ||
|
Athira Pharma
ATHA
|
-114.6 | - | - | $ 269 M | ||
|
BiondVax Pharmaceuticals Ltd.
BVXV
|
-40.14 | - | 0.74 % | $ 768 M | ||
|
Abcam plc
ABCM
|
-0.8 | - | - | $ 4.9 B | ||
|
Galera Therapeutics
GRTX
|
2071.28 | - | -32.59 % | $ 7.61 M | ||
|
Midatech Pharma plc
MTP
|
-35.12 | - | -18.52 % | $ 27.3 M | ||
|
CRISPR Therapeutics AG
CRSP
|
-25.67 | $ 51.42 | -9.71 % | $ 4.62 B | ||
|
Affimed N.V.
AFMD
|
-109.04 | - | -34.95 % | $ 21.5 M | ||
|
Институт стволовых клеток человека
ISKJ
|
4.82 | - | - | - | ||
|
Checkmate Pharmaceuticals
CMPI
|
-77.89 | - | - | $ 231 M | ||
|
Celyad Oncology SA
CYAD
|
-207.62 | - | - | $ 12.5 M | ||
|
Berkeley Lights
BLI
|
-43.36 | - | -7.31 % | $ 87 M | ||
|
Celldex Therapeutics
CLDX
|
-44.38 | $ 28.65 | -4.29 % | $ 1.9 B | ||
|
Generation Bio Co.
GBIO
|
-56.95 | - | - | $ 344 M | ||
|
IMV
IMV
|
-121.19 | - | - | $ 13.1 M | ||
|
Akero Therapeutics
AKRO
|
-30.52 | - | - | $ 3.67 B | ||
|
Akouos
AKUS
|
-31.09 | - | 0.23 % | $ 488 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-489.29 | - | - | $ 7.46 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
36.63 | - | -4.36 % | $ 27 M | ||
|
Freeline Therapeutics Holdings plc
FRLN
|
-102.69 | - | - | $ 384 M | ||
|
Gracell Biotechnologies
GRCL
|
-36.68 | - | - | $ 3.37 B | ||
|
Anika Therapeutics
ANIK
|
-5.72 | $ 14.54 | -1.72 % | $ 208 M | ||
|
Advaxis
ADXS
|
-289.96 | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
-48.33 | - | 5.93 % | $ 314 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-19.95 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
-35.55 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-27.57 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
-19.87 | - | 1.93 % | $ 17.4 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-103.3 | $ 3.12 | -1.27 % | $ 5.14 M | ||
|
Aptose Biosciences
APTO
|
-254.37 | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
-97.25 | - | -39.0 % | $ 4.57 M | ||
|
Albireo Pharma
ALBO
|
-11.27 | - | -0.23 % | $ 916 M | ||
|
AlloVir
ALVR
|
-35.68 | - | 4.14 % | $ 49.1 M | ||
|
Allakos
ALLK
|
-119.89 | - | - | $ 28.6 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-3.73 | $ 21.51 | -2.0 % | $ 2.74 B | ||
|
Allena Pharmaceuticals
ALNA
|
-29.82 | - | 3.16 % | $ 1.9 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-150.49 | - | -11.43 % | $ 502 K |